To Cite:
Behnam
B, Shakiba
M, Ahani
A, Razzaghy Azar
M. Recurrent Hepatitis in Two Iranian Children: A Novel (Q166R) Mutation in EIF2AK3 Leading to Wolcott-Rallison Syndrome,
Hepat Mon.
2013
; 13(6):e10124.
doi: 10.5812/hepatmon.10124.
1.
Rubio-Cabezas O,
Patch AM,
Minton JA,
Flanagan SE,
Edghill EL,
Hussain K,
et al.
Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families. J Clin Endocrinol Metab. 2009; 94(11): 4162-70[DOI][PubMed]
3.
Biason-Lauber A, Lang-Muritano M, Vaccaro T, Schoenle EJ. Loss of kinase activity in a patient with Wolcott-Rallison syndrome caused by a novel mutation in the EIF2AK3 gene. Diabetes. 2002; 51(7): 2301-5[PubMed]
5.
Thomas SE, Dalton LE, Daly ML, Malzer E, Marciniak SJ. Diabetes as a disease of endoplasmic reticulum stress. Diabetes Metab Res Rev. 2010; 26(8): 611-21[DOI][PubMed]
6.
al-Gazali LI, Makia S, Azzam A, Hall CM. Wolcott-Rallison syndrome. Clin Dysmorphol. 1995; 4(3): 227-33[PubMed]
7.
Bin-Abbas B, Shabib S, Hainau B, Al-Ashwal A. Wolcott-Rallison syndrome: clinical, radiological and histological findings in a Saudi child. Ann Saudi Med. 2001; 21(1-2): 73-4[PubMed]
8.
Bonthron DT, Dunlop N, Barr DG, El Sanousi AA, Al-Gazali LI. Organisation of the human PAX4 gene and its exclusion as a candidate for the Wolcott-Rallison syndrome. J Med Genet. 1998; 35(4): 288-92[PubMed]
9.
Stewart FJ, Carson DJ, Thomas PS, Humphreys M, Thornton C, Nevin NC. Wolcott-Rallison syndrome associated with congenital malformations and a mosaic deletion 15q 11-12. Clin Genet. 1996; 49(3): 152-5[PubMed]
10.
Stoss H, Pesch HJ, Pontz B, Otten A, Spranger J. Wolcott-Rallison syndrome: diabetes mellitus and spondyloepiphyseal dysplasia. Eur J Pediatr. 1982; 138(2): 120-9[PubMed]
11.
Delepine M, Nicolino M, Barrett T, Golamaully M, Lathrop GM, Julier C. EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet. 2000; 25(4): 406-9[DOI][PubMed]
12.
Senee V,
Vattem KM,
Delepine M,
Rainbow LA,
Haton C,
Lecoq A,
et al.
Wolcott-Rallison Syndrome: clinical, genetic, and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity. Diabetes. 2004; 53(7): 1876-83[PubMed]
13.
Feng DR, Meng Y, Zhao SM, Shi HP, Wang WC, Huang SZ. [Two novel EIF2AK3 mutations in a Chinese boy with Wolcott-Rallison syndrome]. Zhonghua Er Ke Za Zhi. 2011; 49(4): 301-5[PubMed]
14.
Mihci E, Turkkahraman D, Ellard S, Akcurin S, Bircan I. Wolcott-Rallison syndrome due to a novel mutation (R491X) in EIF2AK3 gene. J Clin Res Pediatr Endocrinol. 2012; 4(2): 101-3[DOI][PubMed]
15.
Reis AF,
Kannengiesser C,
Jennane F,
Manna TD,
Cheurfa N,
Oudin C,
et al.
Two novel mutations in the EIF2AK3 gene in children with Wolcott-Rallison syndrome. Pediatr Diabetes. 2011; 12(3 Pt 1): 187-91[DOI][PubMed]
16.
Sang Y, Liu M, Yang W, Yan J, Chengzhu, Ni G. A novel EIF2AK3 mutation leading to Wolcott-Rallison syndrome in a Chinese child. J Pediatr Endocrinol Metab. 2011; 24(3-4): 181-4[PubMed]
17.
Brickwood S,
Bonthron DT,
Al-Gazali LI,
Piper K,
Hearn T,
Wilson DI,
et al.
Wolcott-Rallison syndrome: pathogenic insights into neonatal diabetes from new mutation and expression studies of EIF2AK3. J Med Genet. 2003; 40(9): 685-9[PubMed]
18.
Loria P, Lonardo A, Anania F. Liver and diabetes. A vicious circle. Hepatol Res. 2013; 43(1): 51-64[DOI][PubMed]
19.
Balasubramanyam M, Singh LP, Rangasamy S. Molecular intricacies and the role of ER stress in diabetes. Exp Diabetes Res. 2012; 2012: 958169[DOI][PubMed]
20.
Chamoun Z, Vacca F, Parton RG, Gruenberg J. PNPLA3/adiponutrin functions in lipid droplet formation. Biol Cell. 2013; [DOI][PubMed]
21.
Zhou B, Li H, Xu L, Zang W, Wu S, Sun H. Osteocalcin reverses endoplasmic reticulum stress and improves impaired insulin sensitivity secondary to diet-induced obesity through nuclear factor-kappaB signaling pathway. Endocrinology. 2013; 154(3): 1055-68[DOI][PubMed]
Readers' Comments